Table 2 Adrenocortical carcinoma patients’ characteristics
No | Age | Sex | Maximum diameter (mm) | Endocrine activity | Capsule invasion | Clinical stage | Chemotherapy | Outcome | Observation period (months) |
|---|---|---|---|---|---|---|---|---|---|
1 | 85 | F | 96 | − | NA | StageIV | − | dead | 1 |
2 | 19 | F | 125 | + | + | StageIII | + | dead | 5 |
3 | 64 | F | 72 | − | NA | StageIV | + | dead | 42 |
4 | 62 | M | 100 | − | + | StageIV | + | dead | 9 |
5 | 64 | F | 105 | − | NA | StageIV | + | dead | 2 |
6 | 66 | F | 70 | − | + | StageIV | + | dead | 30 |
7 | 42 | F | 108 | − | − | StageIV | + | dead | 17 |
8 | 34 | F | 125 | − | − | StageIV | − | dead | 17 |
9 | 72 | F | 18 | − | + | StageI | − | alive | 27 |